Biogen leans into digital therapeutics for multiple sclerosis, teams with Happify Health
Biogen is looking outside its walls for digital solutions to help multiple sclerosis patients. Its new partnership with Happify Health on an MS digital therapeutic is launching under the leadership of a former CVS Health strategist.
Jason Hawbecker, Biogen’s head of strategic partnerships, joined the company just over a year ago, after overseeing the buildout of CVS’ Covid-19 testing platform for the pharmacy retailer. He spent seven years at CVS in a variety of roles in M&A, leading its Aetna acquisition, launching a CVS health venture fund, and building a partnerships team, similar to his role now at Biogen.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.